248 related articles for article (PubMed ID: 28484164)
1. [Morphologic diagnosis of myelodysplastic syndromes].
Matsuda A
Rinsho Ketsueki; 2017; 58(4):336-346. PubMed ID: 28484164
[TBL] [Abstract][Full Text] [Related]
2. [Classification and clinical findings of myelodysplastic syndromes].
Tsuruda K; Hasegawa H; Fuchigami M; Uno N; Morinaga Y; Miyazaki Y; Yanagihara K
Rinsho Byori; 2014 Apr; 62(4):359-68. PubMed ID: 25022065
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of MDS: morphology, chromosome abnormalities and genetic mutations].
Hata T
Rinsho Ketsueki; 2015 Oct; 56(10):1978-84. PubMed ID: 26458436
[TBL] [Abstract][Full Text] [Related]
4. Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.
Font P; Loscertales J; Soto C; Ricard P; Novas CM; Martín-Clavero E; López-Rubio M; Garcia-Alonso L; Callejas M; Bermejo A; Benavente C; Ballesteros M; Cedena T; Calbacho M; Urbina R; Villarrubia J; Gil S; Bellón JM; Diez-Martin JL; Villegas A
Ann Hematol; 2015 Apr; 94(4):565-73. PubMed ID: 25387664
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS).
Cantù Rajnoldi A; Fenu S; Kerndrup G; van Wering ER; Niemeyer CM; Baumann I;
Ann Hematol; 2005 Jul; 84(7):429-33. PubMed ID: 15838669
[TBL] [Abstract][Full Text] [Related]
6. Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization.
Fu CM; Chen ZX; Liu DD; Zhang J; Pan JL; Liang JY
Int J Hematol; 2015 Jan; 101(1):58-66. PubMed ID: 25430081
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic syndromes.
Zhou J; Orazi A; Czader MB
Semin Diagn Pathol; 2011 Nov; 28(4):258-72. PubMed ID: 22195404
[TBL] [Abstract][Full Text] [Related]
8. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
Mufti GJ; Bennett JM; Goasguen J; Bain BJ; Baumann I; Brunning R; Cazzola M; Fenaux P; Germing U; Hellström-Lindberg E; Jinnai I; Manabe A; Matsuda A; Niemeyer CM; Sanz G; Tomonaga M; Vallespi T; Yoshimi A;
Haematologica; 2008 Nov; 93(11):1712-7. PubMed ID: 18838480
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of bone marrow cell dysplasia and its effectiveness in diagnosing myelodysplastic syndrome.
Liang C; Li J; Cheng J; Chen S; Ye Z; Zhang F; Wang Z; Wang F; Peng C; Ouyang J
Hematology; 2018 Mar; 23(2):65-76. PubMed ID: 28675126
[TBL] [Abstract][Full Text] [Related]
11. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
[TBL] [Abstract][Full Text] [Related]
12. Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification.
Font P; Loscertales J; Benavente C; Bermejo A; Callejas M; Garcia-Alonso L; Garcia-Marcilla A; Gil S; Lopez-Rubio M; Martin E; Muñoz C; Ricard P; Soto C; Balsalobre P; Villegas A
Ann Hematol; 2013 Jan; 92(1):19-24. PubMed ID: 22948274
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and classification of myelodysplastic syndromes.
Hasserjian RP; Germing U; Malcovati L
Blood; 2023 Dec; 142(26):2247-2257. PubMed ID: 37774372
[TBL] [Abstract][Full Text] [Related]
14. A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification.
Verburgh E; Achten R; Louw VJ; Brusselmans C; Delforge M; Boogaerts M; Hagemeijer A; Vandenberghe P; Verhoef G
Leukemia; 2007 Apr; 21(4):668-77. PubMed ID: 17301818
[TBL] [Abstract][Full Text] [Related]
15. Morphologic Characteristics of Myelodysplastic Syndromes.
Yuen LD; Hasserjian RP
Clin Lab Med; 2023 Dec; 43(4):577-596. PubMed ID: 37865504
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndromes classification and risk stratification.
Komrokji RS; Zhang L; Bennett JM
Hematol Oncol Clin North Am; 2010 Apr; 24(2):443-57. PubMed ID: 20359636
[TBL] [Abstract][Full Text] [Related]
17. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
18. Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes.
Kawai N; Matsuda A; Jinnai I; Ichimura T; Kayano H; Okamura D; Ishikawa M; Maeda T; Hata T; Miyazaki Y; Asou N; Bessho M; Tomonaga M
Int J Hematol; 2016 Feb; 103(2):227-33. PubMed ID: 26608365
[TBL] [Abstract][Full Text] [Related]
19. Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.
Vercauteren SM; Bashashati A; Wu D; Brinkman RR; Eaves C; Eaves A; Karsan A
Leuk Res; 2009 Dec; 33(12):1636-42. PubMed ID: 19414193
[TBL] [Abstract][Full Text] [Related]
20. The current approach to the diagnosis of myelodysplastic syndromes
Weinberg OK; Hasserjian RP
Semin Hematol; 2019 Jan; 56(1):15-21. PubMed ID: 30573039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
